stockportfolio.pro
Stocks / SHC vs TVTX
SHC vs TVTX
Sotera Health Company and Travere Therapeutics, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Sotera Health Company (SHC) | Travere Therapeutics, Inc. (TVTX) | |
|---|---|---|
| Market cap | $4.7B | $4.5B |
| Revenue (latest FY) | $1.16B | $490.73M |
| Net income (latest FY) | $77.95M | $-25.55M |
| Revenue growth (5y CAGR) | 7.3% | 19.9% |
| Net margin | 6.7% | -5.2% |
| Return on equity | 12.9% | -22.2% |
| P/E ratio | 39.9 | — |
| Dividend yield | — | — |
| Profitable years (of last 10) | 4 | 0 |
| Positive free cash flow | Yes | No |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open SHC — free Open TVTX — freeFrequently asked questions
Which is bigger, SHC or TVTX?
Sotera Health Company is larger by market capitalization — $4.7B versus $4.5B.
Which grows faster, SHC or TVTX?
Over the last five fiscal years, Travere Therapeutics, Inc. grew revenue faster — 19.9%/yr versus 7.3%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.